Welcome to our dedicated page for Inotiv SEC filings (Ticker: NOTV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating toxicology tables, animal-welfare disclosures, and segment margins across Discovery and Safety Assessment versus Research Models can turn Inotiv’s SEC filings into a 300-page puzzle. If you have ever asked, “Where do I find Inotiv insider trading Form 4 transactions or the latest Inotiv quarterly earnings report 10-Q filing?” this page is built for you.
Stock Titan’s AI reads every 10-K, 10-Q, 8-K, and S-4 the moment they post to EDGAR. Our platform extracts cash-flow swings, upcoming FDA audit risks, and contractual earn-out details, then serves plain-English dashboards. You will see Inotiv Form 4 insider transactions real-time, debt-covenant changes, and revenue by service line—all in one view. The same engine powers quick answers to the common search, “Inotiv SEC filings explained simply,” delivering side-by-side trend charts and an Inotiv earnings report filing analysis you can skim in minutes.
Need deeper dives? Use our AI summary links for understanding Inotiv SEC documents with AI, or jump straight to red-lined PDFs. Track an Inotiv executive stock transactions Form 4 alert before material announcements, open an Inotiv annual report 10-K simplified for five-year segment KPIs, review the Inotiv proxy statement executive compensation for pay-for-performance alignment, or scan an Inotiv 8-K material events explained digest after unexpected CRO contract wins. From real-time feeds to curated insights, every filing type is covered so you can focus on decisions, not document hunts.
Amendment No. 5 to Schedule 13D discloses that the Silver Lake–affiliated reporting persons (Global Blue Holding L.P., SL Globetrotter L.P., SL Globetrotter GP Ltd., Silver Lake Technology Associates III Cayman L.P. and Silver Lake (Offshore) AIV GP III Ltd.) have tendered all of their equity interests in Global Blue Group Holding AG (“GB”) in connection with the cash tender offer launched by Shift4 Payments, Inc. and its Swiss merger subsidiary.
The offer, which commenced on 21 March 2025 and expired one minute after 11:59 p.m. (NYC time) on 2 July 2025, met all conditions. The Silver Lake vehicles tendered:
- 34,871,499 ordinary shares held by Cayman Holdings at $7.50 per share
- 4,939,137 Series A preferred shares (convertible into ordinary shares) at $10.00 per share
- 91,230,811 ordinary shares held by Globetrotter at $7.50 per share
- 11,970,487 Series A preferred shares held by Globetrotter at $10.00 per share
In addition, 2,701,935 Global Blue warrants (Cayman Holdings) and 6,548,415 warrants (Globetrotter) were cashed-out and are no longer exercisable. As a result of these transactions, the reporting persons now report 0 shares beneficially owned (0.0% of the class) and thereby cease to be 5% holders as of 3 July 2025.
Following completion of the offer, director Joseph Osnoss resigned from the Global Blue board. The filing attaches an amended Annex A listing directors of the Silver Lake general partners and adds Exhibit 99.1 containing that information.
This amendment is limited to updating ownership, identity disclosures and purpose-of-transaction details; all other information in prior filings remains unchanged.
FAQ
What is the current stock price of Inotiv (NOTV)?
What is the market cap of Inotiv (NOTV)?
What are the core business segments of Inotiv Inc?
Which industries does Inotiv Inc serve?
How does Inotiv differentiate itself from competitors?
What type of research models does Inotiv offer?
What role does regulatory compliance play in Inotiv's operations?
How does Inotiv support the drug discovery process?
What technological innovations does Inotiv incorporate in its services?
